Shares of Sarepta Therapeutics fell close to 37% on Friday after reports emerged that the US Food and Drug Administration is considering whether to halt the distribution of Elevidys, the company’s flagship gene therapy for Duchenne Muscular Dystrophy (DMD). The move comes amid an ongoing investigation into multiple patient deaths…
Talen Energy (NYSE: TLN) shares surged over 25% on Friday, reaching $330.99 in intraday trading and setting a new…
Donald Trump filed a sweeping lawsuit against media magnate Rupert Murdoch, News Corp, Dow Jones, and two Wall Street…
El Salvador, once hailed as the global trailblazer for national Bitcoin adoption, is quietly shifting gears. After making headlines…
India’s anti-money laundering agency, the Enforcement Directorate, has summoned officials from Google and Meta on Monday in relation to…
HDFC Bank, India’s biggest private lender, reported its Q1 FY26 numbers on Saturday, and it was a strong showing.…
Wall Street is heading into a crucial stretch next week as investors are gearing up for a packed schedule:…
Global upstream merger and acquisition (M&A) activity saw a significant decline in the first half of 2025, reaching just…
The FTSE 100 Index remained steady this month, mirroring the performance of other global indices, such as the Nasdaq…